These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 26457592)
21. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association. Bahuau M; Flintoff W; Assouline B; Lyonnet S; Le Merrer M; Prieur M; Guilloud-Bataille M; Feingold N; Munnich A; Vidaud M; Vidaud D Am J Med Genet; 1996 Dec; 66(3):347-55. PubMed ID: 8985499 [TBL] [Abstract][Full Text] [Related]
22. Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome. Bahuau M; Houdayer C; Assouline B; Blanchet-Bardon C; Le Merrer M; Lyonnet S; Giraud S; Récan D; Lakhdar H; Vidaud M; Vidaud D Am J Med Genet; 1998 Jan; 75(3):265-72. PubMed ID: 9475595 [TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlation in type 1 neurofibromatosis: pMet992del mutation and milder disease. Batalla A; Iglesias-Puzas Á; Freire-Bruno J; Herrero-Hermida J; Flórez Á Pediatr Dermatol; 2018 Sep; 35(5):e268-e271. PubMed ID: 29968256 [TBL] [Abstract][Full Text] [Related]
24. [Genetic identification of a case of Noonan syndrome and treatment with growth hormone]. Pi G; Zúñiga A; Gastaldo E; Ortiz M Med Clin (Barc); 2014 Apr; 142(8):378-9. PubMed ID: 24054841 [No Abstract] [Full Text] [Related]
25. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1. Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999 [TBL] [Abstract][Full Text] [Related]
26. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998 [TBL] [Abstract][Full Text] [Related]
27. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins. Nyström AM; Ekvall S; Strömberg B; Holmström G; Thuresson AC; Annerén G; Bondeson ML Acta Paediatr; 2009 Apr; 98(4):693-8. PubMed ID: 19120036 [TBL] [Abstract][Full Text] [Related]
28. A novel mutation in NF1 is associated with diverse intra-familial phenotypic variation and astrocytoma in a Chinese family. Banerjee S; Dai Y; Liang S; Chen H; Wang Y; Tang L; Wu J; Huang H J Clin Neurosci; 2016 Sep; 31():182-4. PubMed ID: 27234610 [TBL] [Abstract][Full Text] [Related]
29. Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers. Wiest V; Eisenbarth I; Schmegner C; Krone W; Assum G Hum Mutat; 2003 Dec; 22(6):423-7. PubMed ID: 14635100 [TBL] [Abstract][Full Text] [Related]
30. [Molecular genetic diagnosis of neurofibromatosis type I]. Polgár N; Komlósi K; Hadzsiev K; Illés T; Melegh B Orv Hetil; 2011 Mar; 152(11):415-9. PubMed ID: 21362601 [TBL] [Abstract][Full Text] [Related]
31. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. Sharif S; Upadhyaya M; Ferner R; Majounie E; Shenton A; Baser M; Thakker N; Evans DG J Med Genet; 2011 Apr; 48(4):256-60. PubMed ID: 21278392 [TBL] [Abstract][Full Text] [Related]
32. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients. De Raedt T; Maertens O; Chmara M; Brems H; Heyns I; Sciot R; Majounie E; Upadhyaya M; De Schepper S; Speleman F; Messiaen L; Vermeesch JR; Legius E Genes Chromosomes Cancer; 2006 Oct; 45(10):893-904. PubMed ID: 16830335 [TBL] [Abstract][Full Text] [Related]
33. Patterns of Novel Alleles and Genotype/Phenotype Correlations Resulting from the Analysis of 108 Previously Undetected Mutations in Patients Affected by Neurofibromatosis Type I. Bonatti F; Adorni A; Matichecchia A; Mozzoni P; Uliana V; Pisani F; Garavelli L; Graziano C; Gnoli M; Carli D; Bigoni S; Boschi E; Martorana D; Percesepe A Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28961165 [TBL] [Abstract][Full Text] [Related]
34. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1. Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990 [TBL] [Abstract][Full Text] [Related]
35. NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies. Ponti G; Martorana D; Pellacani G; Ruini C; Loschi P; Baccarani A; De Santis G; Pollio A; Neri TM; Mandel VD; Maiorana A; Maccio L; Maccaferri M; Tomasi A Anticancer Res; 2014 Jun; 34(6):3021-30. PubMed ID: 24922668 [TBL] [Abstract][Full Text] [Related]
36. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Pasmant E; Sabbagh A; Spurlock G; Laurendeau I; Grillo E; Hamel MJ; Martin L; Barbarot S; Leheup B; Rodriguez D; Lacombe D; Dollfus H; Pasquier L; Isidor B; Ferkal S; Soulier J; Sanson M; Dieux-Coeslier A; Bièche I; Parfait B; Vidaud M; Wolkenstein P; Upadhyaya M; Vidaud D; Hum Mutat; 2010 Jun; 31(6):E1506-18. PubMed ID: 20513137 [TBL] [Abstract][Full Text] [Related]
37. Clinical lumping and molecular splitting of LEOPARD and NF1/NF1-Noonan syndromes. Sarkozy A; Schirinzi A; Lepri F; Bottillo I; De Luca A; Pizzuti A; Tartaglia M; Digilio MC; Dallapiccola B Am J Med Genet A; 2007 May; 143A(9):1009-11. PubMed ID: 17366582 [No Abstract] [Full Text] [Related]
38. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1. Jeong SY; Park SJ; Kim HJ J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075 [TBL] [Abstract][Full Text] [Related]